Your browser doesn't support javascript.
loading
The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Zhao, Y; Wu, L; Lu, Q; Gao, X; Zhu, X; Yao, X; Li, L; Li, W; Ding, Y; Song, Z; Liu, L; Dang, N; Zhang, C; Liu, X; Gu, J; Wang, J; Geng, S; Liu, Q; Guo, Y; Dong, L; Su, H; Bai, L; O'Malley, J T; Luo, J; Laws, E; Mannent, L; Ruddy, M; Amin, N; Bansal, A; Ota, T; Wang, M; Zhang, J.
Afiliação
  • Zhao Y; Peking University People's Hospital, Beijing, China.
  • Wu L; Hangzhou First People's Hospital, Hangzhou, China.
  • Lu Q; The Second Xiangya Hospital of Central South University, Changsha, China.
  • Gao X; The First Hospital of China Medical University, Shenyang, China.
  • Zhu X; Wuxi Second People's Hospital, Jiangsu, China.
  • Yao X; Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing, China.
  • Li L; Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Li W; Huashan Hospital, Fudan University, Shanghai, China.
  • Ding Y; Shanghai Skin Disease Hospital, Shanghai, China.
  • Song Z; The Southwest Hospital of AMU, Chongqing, China.
  • Liu L; Peking University First Hospital, Beijing, China.
  • Dang N; Jinan Central Hospital, Jinan, China.
  • Zhang C; Peking University Third Hospital, Beijing, China.
  • Liu X; University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Gu J; Changhai Hospital of Shanghai, Shanghai, China.
  • Wang J; Ningbo No.2 Hospital, Ningbo, China.
  • Geng S; The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Liu Q; Tianjin Medical University General Hospital, Tianjin, China.
  • Guo Y; Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Dong L; Research & Development, Sanofi, Shanghai, China.
  • Su H; Research & Development, Sanofi, Shanghai, China.
  • Bai L; Research & Development, Sanofi, Shanghai, China.
  • O'Malley JT; Research & Development, Sanofi, Cambridge, MA, USA.
  • Luo J; Research & Development, Sanofi, Indianapolis, IL, USA.
  • Laws E; Research & Development, Sanofi, Bridgewater, MA, USA.
  • Mannent L; Research & Development, Sanofi, Paris, France.
  • Ruddy M; Research & Development, Regeneron, New York, NY, USA.
  • Amin N; Research & Development, Regeneron, New York, NY, USA.
  • Bansal A; Research & Development, Regeneron, New York, NY, USA.
  • Ota T; Research & Development, Regeneron, New York, NY, USA.
  • Wang M; Medical, Sanofi China, Shanghai, China.
  • Zhang J; Peking University People's Hospital, Beijing, China.
Br J Dermatol ; 186(4): 633-641, 2022 04.
Article em En | MEDLINE | ID: mdl-34358343
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Eczema Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Br J Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Eczema Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Br J Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China